S2

Simcere Pharmaceutical Group LtdFRA Simcere Pharmaceutical Stock Report

Last reporting period 31 Dec, 2023

Updated —

Last price

Market cap $B

2.018

Small

Exchange

XFRA - Deutsche Boerse AG

View Section: Eyestock Rating

Simcere Pharmaceutical Fair Value

S2

S2P.F stock is not valued by Eyestock.

Historical price or reporting data is not enough to analyze the value of the company

Discover Undervalued Companies


Simcere Pharmaceutical Valuation

Price chart is not available

1y
3y
5y
All time
Market price

Current market price

Fair value

Min value

Max value

14.11.2024

Market price:

* Eyestock is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on eyestock.io represent a recommendation to buy or sell a security.

Simcere Pharmaceutical Group Ltd price metrics

-11.4

Annual return (geometric mean)

51.84

Risk (standard deviation) of returns

β

0.78

Beta (volatility compared to market)

It means that S2P.F stock is less volatile than the broader market
View Section: Profitability